Clinical Studies

Diagnostic Clinical Studies
 
The clinical landscape of effectively dealing with various disease states is continually changing as scientists and researchers discover new patient care pathways. Learn about the key clinical studies and trends emerging around the world as physicians try to improve patient outcomes and overall population health.
Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.
 

Clinical Studies

Aiming to Close the Knowledge Gap

Learn about new key diagnostic clinical studies for important disease states like COVID-19 and sepsis.
Homepage-Icons-90-percent

Study validates semi-quantitative diagnostic method with 90% sensitivity



Homepage-Icons-100-percent

Study shows 100% sensitivity for two accelerated diagnostic pathways


Homepage Icons 87.59 percent

Multi-center study finds 87.59% auto verification pass accurate rate


 

Study of 3.2-million people shows seropositivity = decreased risk of infection

 

Read more

Study shows abnormal MDW (> 20.0) increased sepsis probability

 

Read more

Estimating-Asymptomatic-COVID

Data suggests an asymptomatic infection rate of 17% rather than the estimated 80%

Preventing-COVID-Campus

In simulations, colleges can prevent up to 96% of COVID-19 infections with common measures

Pooled-Surveillance-Testing

51% of students who tested positive were asymptomatic

SARS-CoV-2-School-Reopening 

LA school district study finds 50% of transmissions occur from asymptomatic persons

Testing-Nursing-Residents 

14% of Maryland nursing care residents who died from COVID-19 were asymptomatic at initial testing

Trends

Sharing best practices from around the world

Learn about how physicians around the world are tackling important disease states like COVID-19 and sepsis.
Homepage-Icons-wait-time

U.K. hospital reduces patient wait times following introduction of Access hsTnI

 

Clinical reference lab turns to mass antigen testing in-house for faster results

Study7-IgM-IgG 

Maximizing serology testing to combat COVID-19 surge

IL-6 testing as a standard for COVID-19 patients

Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.